ITCI Trade on Dec 24, 2019 08:25 from beno: Tradervue User Stock Trades.

Fundamentals

Shares Outstanding: 55.261m
Cash: 102.162m
Current liabilities: 33.373m
Current ratio: 7.77
NWC (total current assets - total current liabilities): 226.083m
Monthly Burn rate (net cash used in operating activities / months): 10.325m
Estimated current cash: 76.3m
Accumulated deficit: 670m
Book value per share (Stock holder equity / Shares outstanding): 4.10
Baby Shelf Exemption price per share: 1.36

Catalysts / News / Painting the picture

FDA Approves Intra-Cellular Therapies Novel Antipsychotic, CAPLYTA® (lumateperone) for the Treatment of Schizophrenia in Adults
Enough cash for 7 months - Would need more $$ for marketing new FDA approved drug
High %SF (20%) - shorts gonna get run over
Has an August 30th S-3 with a $350m base prospectus, and a $75m ATM prospectus (included in base), not used yet

Technical Analysis

-Huge swing trend up blowing past all levels from late 2016, from 13 to 44
-Levels: 18, 25, 28, 31, 34, 36, 38, 39, 43

Original Plan / Strategy

First Test long of 40 level PM

Review

40 Level was very clean, had two fantasy orders at that level, first got hit before I put my fantasy sell, second order got hit on the second bounce (left orders there because it was holding nicely). Both fantasy sells got hit within 1 minute of each other